The content on this site is intended for healthcare professionals only
KEYNOTE048: First line pembrolizumab for recurrent or metastatic head and neck s...
Prof Barbara Burtness - Yale Cancer Center, New Haven, USA
22 Oct 2018
ESMO 2018: Highlights
Prof Gordon McVie , Will Davies
22 Oct 2018
The promise of immunotherapy in head and neck, and prostate cancer
Dr Luis Larrea - NISA, Valencia, Spain
7 Aug 2018
MyPathway study: a novel precision oncology multiple basket trial
Dr Mary S. Beattie - Genentech, USA
6 Jul 2018
Editor's Choice for June 2018
Prof Gordon McVie - Founding Editor, ecancer
4 Jul 2018
Novel fusion proteins to target PD-L1 in HPV associated cancers
Dr James Gulley - Center for Cancer Research, Washington, USA
4 Jun 2018
Phase I study results of M7824 for patients with HPV associated cancers
Dr Julius Strauss - Center for Cancer Research, Washington, USA
4 Jun 2018
Comment: Aspirin with acid-reducing medicine reduces chance of oesophageal cance...
Dr Andrew Epstein and Prof Richard Schilsky
4 Jun 2018
Maintenance chemotherapy extends life for children with rare rhabdomyosarcoma
Dr Gianni Bisogno - University Hospital of Padova, Padova, Italy
3 Jun 2018
Comment: Paediatric rhabdomyosarcoma survival extended with maintenance chemothe...
Prof Richard Schilsky & Dr Gianni Bisogno
3 Jun 2018
Paediatric rhabdomyosarcoma survival extended with maintenance chemotherapy
Dr Gianni Bisogno - University Hospital of Padova, Padova, Italy
3 Jun 2018
What will we expect from novel therapies for oesophageal and gastric malignancie...
Prof Ramon De Mello - University of Algarve, Faro, Portugal
2 Jun 2018